Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in DSGN — Design Therapeutics, Inc.

CIK 1263508 NEW YORK, NY
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$38,756,882
+$11,242,077 QoQ
Shares Held
2,678,430
+3.6% QoQ
Ownership
4.28%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#3
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. DSGN ranks #38 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in DSGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,756,882 2,678,430
2026-03-31 $27,514,805 2,585,978
2025-12-31 $20,946,468 2,233,099
2025-09-30 $12,898,001 1,712,882
2025-06-30 $5,772,412 1,712,882
2025-03-31 $6,730,778 1,743,725
2024-12-31 $10,758,783 1,743,725
2024-09-30 $9,381,240 1,743,725
2024-06-30 $5,679,234 1,695,294
2024-03-31 $6,698,343 1,662,120
2023-12-31 $3,975,000 1,500,000
2023-09-30 $3,540,000 1,500,000
2023-06-30 $3,150,000 500,000
2023-03-31 $3,617,120 626,884
2022-12-31 $7,101,264 692,131
2022-09-30 $24,020,553 1,436,636
2022-06-30 $20,112,904 1,436,636
2022-03-31 $23,201,671 1,436,636
2021-12-31 $30,758,376 1,436,636
2021-09-30 $21,104,182 1,436,636
2021-06-30 $28,574,690 1,436,636
2021-03-31 $42,955,416 1,436,636